Patient 1, 54 years old, was diagnosed with estrogen receptor (ER–)/progesterone receptor (PR‒)/HER2+++ locally advanced (T4bN0M0) breast cancer in August 2019 (Table 1). This evidence concerns the gene ERBB2 and breast carcinoma.